
    
      This is a drug use surveillance planned to examine the safety and efficacy of ramelteon
      tablets when used in the routine clinical setting in patients with sleep-onset difficulty
      associated with insomnia (planned sample size, 3000)

      The usual adult dosage is 8 mg of ramelteon administered orally once daily at bedtime.
    
  